ACT 582093/2023

—·EP3769722: LOW PROFILE DELIVERY SYSTEM FOR TRANSCATHETER HEART VALVE

Verfahrensdetails: Status
—
Verfahrensart
Verletzung
Kategorie
Hauptverletzungsklage
Parteien: Kläger
Edwards Lifesciences Corporation
Vertreter: Jens Olsson; Siddharth Kusumakar; Tessa Waldron
Beklagte
Meril Life Sciences Pvt Ltd.
VAB-LOGISTIK, UAB
SMIS INTERNATIONAL OÜ
Meril GmbH
Sormedica UAB
INTERLUX, UAB
Vertreter: Andreas von Falck (Hogan Lovells International LLP); Alexander Klicznik (Hogan Lovells International LLP)
Division: Nordic-Baltic RD
Richter: Stefan Johansson · Presiding Judge and Judge-Rapporteur
Kai Härmand · Legally Qualified Judge
Mélanie Bessaud · Legally Qualified Judge
Stefan Wilhelm · Technically Qualified Judge
Technology: Medical Devices · Implants · Pharmaceutical & Medical
Sprache: —
Erste Entscheidung: 10. Dez. 2024
Letzte Entscheidung: 21. Juli 2025

Entscheidungen

2024-12-10
Infringement Action
The Nordic-Baltic Regional Division issued a post-interim conference procedural order in Edwards Lifesciences Corporation v Meril Life Sciences and others (UPC_CFI_380/2023, EP 3 769 722 — a transcatheter heart valve patent). The order resolved multiple procedural disputes including: admissibility of additional invalidity attacks raised in the counterclaim for revocation; how to deal with the public interest defence; request for a CJEU preliminary reference (deferred); request for a Court expert (rejected); and practical arrangements for the oral hearing.
Rechtsfragen:Admissibility of invalidity attacks in counterclaim for revocationPublic interest defence in medical device patent infringementPreliminary referral to CJEUCourt expert requestTranscatheter heart valve patent

Dokumente